a7698d
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2025
Commission File Number: 001-41411
Haleon plc
(Translation
of registrant’s name into English)
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F:
EXHIBIT INDEX
|
Exhibit
Number
|
Description
|
|
99.1
|
04
April 2025 - Notice of Annual General Meeting (AGM)
|
99.1
Haleon plc: Notice of Annual General Meeting (AGM)
4 April 2025: Haleon
plc (the "Company" or "Haleon") today announces that the following
documents have been made available to
shareholders:
1. Notice
of 2025 Annual General Meeting (the "Notice");
2. Form
of Proxy for 2025 Annual General Meeting; and
3. AGM
Voting Instruction Card.
Haleon's AGM will again be a virtual meeting, broadcast under
studio conditions from the Company's London offices at 3.00pm (BST)
on Wednesday 28 May 2025. The Notice is available on the Company's
website at https://www.haleon.com/investors/shareholder-information/annual-general-meetings,
and includes full details of the business to be conducted and
joining instructions.
In compliance with UK Listing Rule 6.4.1R, a copy of the above
documents has been submitted to the National Storage Mechanism and
will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
Amanda Mellor
Company Secretary
Enquiries
|
Investors
|
Media
|
|
Jo Russell
|
+44 7787 392441
|
Zoë Bird
|
+44 7736 746167
|
|
Rakesh Patel
|
+44 7552 484646
|
Victoria Durman
|
+44 7894 505730
|
|
Emma White
|
+44 7823 523562
|
|
|
|
Email: investor-relations@haleon.com
|
Email: corporate.media@haleon.com
|
About Haleon
Haleon (LSE / NYSE: HLN) is a global leader in consumer health,
with a purpose to deliver better everyday health with humanity.
Haleon's product portfolio spans five major categories - Oral
Health, Pain Relief, Respiratory Health, Digestive Health and
Other, and Vitamins, Minerals and Supplements (VMS). Its
long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren,
Theraflu, Otrivin, Polident, parodontax and Centrum - are built on
trusted science, innovation and deep human
understanding.
For more information, please visit www.haleon.com.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
|
HALEON PLC
(Registrant)
|
|
Date:
April 04, 2025
|
By:
|
/s/
Amanda Mellor
|
|
|
|
Name:
|
Amanda
Mellor
|
|
|
|
Title:
|
Company
Secretary
|
エドガーで原本を確認する